These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 11226896

  • 1. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
    Figarella I, Barbaud A, Lecompte T, De Maistre E, Reichert-Penetrat S, Schmutz JL.
    Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
    [Abstract] [Full Text] [Related]

  • 2. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH, Weger W, Reiter H, Arbab E, Kränke B, Aberer W.
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [Abstract] [Full Text] [Related]

  • 3. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P.
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [Abstract] [Full Text] [Related]

  • 4. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH.
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [Abstract] [Full Text] [Related]

  • 5. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A, Fritsch P, Reider N.
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [Abstract] [Full Text] [Related]

  • 6. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U, Juschka U, Kuner N, Hausen BM, Krohn K.
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [Abstract] [Full Text] [Related]

  • 7. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration.
    Jappe U, Reinhold D, Bonnekoh B.
    Contact Dermatitis; 2002 Jan; 46(1):29-32. PubMed ID: 11918584
    [Abstract] [Full Text] [Related]

  • 8. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R, Glässl A, Landthaler M, Stolz W.
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract] [Full Text] [Related]

  • 9. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U.
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [Abstract] [Full Text] [Related]

  • 10. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A.
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [Abstract] [Full Text] [Related]

  • 11. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
    Koch P, Münssinger T, Rupp-John C, Uhl K.
    J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
    [Abstract] [Full Text] [Related]

  • 12. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C, Vial-Dupuy A, Autegarden JE, Amsler E, Gaouar H, Abuaf N, Pecquet C, Francès C, Soria A.
    Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
    [Abstract] [Full Text] [Related]

  • 13. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
    Trautmann A, Seitz CS.
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
    [Abstract] [Full Text] [Related]

  • 14. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
    Boehncke WH, Weber L, Gall H.
    Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
    [Abstract] [Full Text] [Related]

  • 15. The complex clinical picture of side effects to anticoagulation.
    Trautmann A, Seitz CS.
    Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S, Torres MJ, Rodríguez-Pena R, Blanca-Lopez N, Fernandez TD, Antunez C, Canto G, de Luque V, Mayorga C.
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [Abstract] [Full Text] [Related]

  • 17. Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.
    Tan E, Thompson G, Ekstrom C, Lucas M.
    Intern Med J; 2018 Jan; 48(1):73-77. PubMed ID: 29314514
    [Abstract] [Full Text] [Related]

  • 18. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B, Bonneau JC, Le Sellin J, Gay G, Leclere JM, Drouet M.
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [Abstract] [Full Text] [Related]

  • 19. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary.
    Gómez-Outes A, Gómez de la Bárcena C, Martínez-González J.
    Br J Dermatol; 2008 Apr; 158(4):869-70. PubMed ID: 18284394
    [No Abstract] [Full Text] [Related]

  • 20. Management of cutaneous type IV hypersensitivity reactions induced by heparin.
    Ludwig RJ, Schindewolf M, Utikal J, Lindhoff-Last E, Boehncke WH.
    Thromb Haemost; 2006 Nov; 96(5):611-7. PubMed ID: 17080218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.